Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.96) per share. This is a 62.71 percent decrease over losses of $(0.59) per share from the same period last year.
Related Posts
Top 4 Defensive Stocks That You May Want To Dump This Month
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
Lawmaker Warns San Francisco Faces ‘Public Health Mess’ Over Monkeypox Vaccine Shortage
A California state legislator representing the Bay Area declared San Francisco is "veering toward a public health mess" after the city’s Department of Public Health acknowledged it is running out of monkeypox vaccine and will have to shutter one of its clinics until the supply is replenished.
Why Stoke Therapeutics Is Trading Lower Today?
Stoke Therapeutics Inc (NASDAQ: STOK) shares are trading lower after the company released new safety & efficacy data from STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) study in children and